Aspen Aerogels (NYSE:ASPN) Upgraded at StockNews.com

StockNews.com upgraded shares of Aspen Aerogels (NYSE:ASPN) to a sell rating in a research report sent to investors on Saturday.

Other research analysts also recently issued reports about the company. Canaccord Genuity Group cut their price target on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Roth Mkm cut their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Piper Sandler cut their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. HC Wainwright reiterated a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a report on Wednesday, October 16th. Finally, Barclays cut their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.11.

Aspen Aerogels Trading Up 4.8 %

Shares of NYSE ASPN opened at $12.03 on Friday. Aspen Aerogels has a twelve month low of $10.67 and a twelve month high of $33.15. The business has a fifty day simple moving average of $12.50 and a two-hundred day simple moving average of $18.81. The firm has a market cap of $986.65 million, a PE ratio of 1,203.70 and a beta of 2.14. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently modified their holdings of the stock. nVerses Capital LLC lifted its holdings in shares of Aspen Aerogels by 45.0% in the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after buying an additional 1,800 shares during the period. Quest Partners LLC lifted its holdings in shares of Aspen Aerogels by 263.3% in the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock valued at $205,000 after buying an additional 5,361 shares during the period. Pursue Wealth Partners LLC acquired a new position in shares of Aspen Aerogels in the 3rd quarter valued at about $222,000. Mesirow Financial Investment Management Inc. acquired a new position in shares of Aspen Aerogels in the 3rd quarter valued at about $252,000. Finally, Kovitz Investment Group Partners LLC acquired a new position in shares of Aspen Aerogels in the 3rd quarter valued at about $263,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.